231 related articles for article (PubMed ID: 31066103)
1. Targeting HIV-TB coinfection by developing novel piperidin-4-substituted imines: Design, synthesis, in vitro and in silico studies.
Kumar A; Revathi R; Sriram D; Curreli F; Debnath AK; Pai KS; Kini SG
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800358. PubMed ID: 31066103
[TBL] [Abstract][Full Text] [Related]
2. Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents.
Revathi R; Venkatesha Perumal R; Pai KS; Arunkumar G; Sriram D; Kini SG
Drug Des Devel Ther; 2015; 9():3779-87. PubMed ID: 26229439
[TBL] [Abstract][Full Text] [Related]
3. Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives.
Chitre TS; Patil SM; Sujalegaonkar AG; Asgaonkar KD; Khedkar VM; Garud DR; Jha PC; Gaikwad SY; Kulkarni SS; Choudhari A; Sarkar D
Curr Comput Aided Drug Des; 2019; 15(5):433-444. PubMed ID: 30574853
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
5. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
6. Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis.
Gama NH; Elkhadir AY; Gordhan BG; Kana BD; Darkwa J; Meyer D
Biometals; 2016 Aug; 29(4):637-50. PubMed ID: 27246555
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.
Sriram D; Yogeeswari P; Gopal G
Eur J Med Chem; 2005 Dec; 40(12):1373-6. PubMed ID: 16129516
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Pharmacological Evaluation, In silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(substituted)-2-methyl- 3-(4-oxo-2-phenyl quinazolin-3(4H)-yl)isothioureas.
Sulthana MT; Alagarsamy V; Chitra K
Med Chem; 2021; 17(4):352-368. PubMed ID: 32807063
[TBL] [Abstract][Full Text] [Related]
12. MoS
Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
[TBL] [Abstract][Full Text] [Related]
13. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anti-HIV and antitubercular activities of nelfinavir diester derivatives.
Sriram D; Yogeeswari P; Dinakaran M; Sowmya M
Biomed Pharmacother; 2008 Jan; 62(1):1-5. PubMed ID: 17890044
[TBL] [Abstract][Full Text] [Related]
15. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of some isonicotinic acid hydrazide analogues as potential antitubercular agents.
Atta A; Fahmy S; Rizk O; Sriram D; Mahran MA; Labouta IM
Bioorg Chem; 2018 Oct; 80():721-732. PubMed ID: 30077175
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
Kumar G; Krishna VS; Sriram D; Jachak SM
Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
[TBL] [Abstract][Full Text] [Related]
18. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
19. New azaaurone derivatives as potential multitarget agents in HIV-TB coinfection.
Leite DI; Campaniço A; Costa PAG; Correa IA; da Costa LJ; Bastos MM; Moreira R; Lopes F; Jordaan A; Warner DF; Boechat N
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300560. PubMed ID: 38032154
[TBL] [Abstract][Full Text] [Related]
20. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
